|
Vol. 3, No. 4
|
Friday, Jan. 29, 1999
A study published yesterday, Jan. 28, in the journal Neuron is among the first to show that genetically modified mice exhibiting symptoms of Parkinson's disease can survive for at least one year without daily L-dopa treatments after a single gene therapy injection. (more)
The success of this year's WWAMI Program state legislative conferences continued on Jan. 19 as 60 of Montana's 115 senators and representatives gathered in Bozeman to receive the annual update on the program from UW School of Medicine officials. (more)
In the "Controversies" section of the Jan. 27 issue of the Journal of the American Medical Association (JAMA), physician Matthew Hollon, a senior fellow in the UW Division of General Internal Medicine, questions the purported merits of direct-to-consumer prescription drug advertising. (more)
Julie Overbaugh, UW associate professor of microbiology, has received a 1999 Elizabeth Glaser Scientist Award for her research on pediatric HIV/AIDS. (more)
Michael V. Vitiello, professor of psychiatry and behavioral sciences, has been appointed to chair the UW Office of Research Grant and Contract Process Enhancement Team (GC-PET) and to work on other special assignments, such as developing the Advanced Technology Initiative Faculty Clusters program. (more)
A group of new UW faculty will take a bus tour of Washington June 14 to 18
to
learn more about the state, see where their students come from, get
ideas for
research or community service, meet with constituents and enjoy the
company
of other new faculty from disciplines and campuses across the
University.
(more)
All rights reserved. |